BREAST CANCER SURVIVOR SHARES HER POWERFUL STORY OF HOW GENETIC TESTING PLAYED A PIVOTAL ROLE IN BECOMING CANCER-FREE

JUNE IS NATIONAL CANCER SURVIVOR MONTH SAN FRANCISCO, June 9, 2023 /PRNewswire/ — BACKGROUND:According to the American Cancer Society (ACS), as of January 2022, it is estimated that there are 18.1 million cancer survivors in the United States. This represents approximately 5.4% of the population. ACS has also reported the risk of dying from cancer in … Read more

GNC Starts Beyond Raw® Week with Three Revolutionary New Product Drops

Beyond Raw® adds Dynamic Whey, Dynamic Gainer, and Precision Amino to its science-backed portfolio PITTSBURGH, June 9, 2023 /PRNewswire/ — Beyond Raw® is built on strength, performance, and unmatched innovation that enables even the strongest of athletes to exceed their goals. Established in 2010, and home to some of GNC’s most powerful advancements like Chemistry Labs™ and … Read more

Sector to Reach $1.53 Billion by 2028 at a 35.7% CAGR

DUBLIN, June 9, 2023 /PRNewswire/ — The “Artificial Intelligence (AI) in MRI Market – Forecasts from 2023 to 2028” report has been added to ResearchAndMarkets.com’s offering. The artificial intelligence in MRI market is projected to grow at a CAGR of 35.7% to reach US$1,539.622 million in 2028 from US$181.720 million in 2021. Artificial Intelligence (AI) is … Read more

Immunohistochemistry (IHC) Market worth $4.7 billion

CHICAGO, June 9, 2023 /PRNewswire/ — The immunohistochemistry (IHC) industry is poised for remarkable growth and advancements in the near future. With increasing demand for precise and personalized diagnostics, coupled with ongoing developments in technology and biomarker research, the IHC market is set to witness significant expansion. Immunohistochemistry techniques enable the visualization and analysis of … Read more

Postbiotics, Connected Diet Care, Digital OTC Therapy and AI-powered Precision Skin, Hair, and Oral Care

DUBLIN, June 9, 2023 /PRNewswire/ — The “Self-Care: Enabling Technologies and Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. Self-Care: Enabling Technologies and Growth Opportunities comprises an analysis of physical self-care technologies and growth opportunities. It also provides actionable insights into the patent landscape across each physical self-care segment. Self-care is a proactive and customized … Read more

L.A. Care and Blue Shield Promise Bring Much Needed Community Resource Center to North Long Beach, Enriching the Community with Free Health-Focused Programs and Services USA – English USA – English USA – español Italia – Italiano

LONG BEACH, Calif., June 9, 2023 /PRNewswire/ — L.A. Care Health Plan and Blue Shield of California Promise Health Plan today announce the official grand opening celebration for their Community Resource Center in Long Beach. The Center, located at 5599 Atlantic Avenue, is one of 12 out of 14 planned centers jointly operated by the health … Read more

Headline, Upfront, Milestone and Royalty Data for 1,000+ Deals

DUBLIN, June 9, 2023 /PRNewswire/ — The “Global Respiratory Partnering 2010-2023: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering. Global Respiratory Partnering 2010 to 2023 provides the full collection of over 1,000 Respiratory disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010. Most of the deals included within … Read more

Skupina Menarini oznamuje na kongresu Evropské hematologické asociace údaje o podskupině NEXPOVIO® (selinexor) ze studie BOSTON a podtrhuje klinický potenciál u relapsu mnohočetného myelomu nereagujícího na jinou léčbu USA – čeština USA – English USA – English USA – español USA – Pусский USA – Deutsch USA – Polski USA – Français

Údaje prokazují významné 71% snížení rizika progrese onemocnění nebo úmrtí ve větvi selinexor + bortezomib + dexametazon (SVd). oproti větvi bortezomib + dexametazon (Vd) u pacientů dosud nevystavených inhibitoru proteazomu  Data ukazují významné 47% snížení rizika úmrtí při použití SVd oproti Vd u pacientů s mnohočetným myelomem, kteří nereagují na léčbu lenalidomidem  FLORENCIE, Itálie, 9. … Read more

MOLLI Surgical Honoured as a Top Workplace in Health Care for 2023

MOLLI Surgical selected as one of the Best Workplaces in Health Care for second consecutive year TORONTO, June 9, 2023 /PRNewswire/ — MOLLI Surgical is proud to announce that our organization has been recognized on the 2023 Best Workplaces™ in Health Care list. The company received this honour after a thorough and independent analysis conducted by … Read more

Analysis of How and Why companies Enter Companion Diagnostics Partnering Deals

DUBLIN, June 9, 2023 /PRNewswire/ — The “Global Companion Diagnostics Partnering Terms and Agreements 2010-2023” report has been added to ResearchAndMarkets.com’s offering. The Global Companion Diagnostics Partnering Terms and Agreements 2010-2023 report provides comprehensive access to available deals and contract documents for over 550 companion diagnostics deals and agreements entered into by the worlds leading healthcare … Read more